Avixa Pharma started its activities in the sector in 1981 with the establishment of Avkan Pharmacy and a few years later with the establishment of a chemical raw material production facility in Gaziantep. In the following years, it will continue its activities with the pharmacy, pharmaceutical warehouse, pharmaceutical conmpany and R&D company established in Istanbul and will continue to exist in Turkey and abroad by increasing its targets in the coming periods.

MILESTONES

1981

Avkan Pharmacy opened in Gaziantep.

1983

Establishment of a chemical raw material production facility.

2004

Avkan Pharmacy was opened in Istanbul by the second generation Hüseyin Avkan.

2011

Establishment of Oksijen Drug Wholesaler in Istanbul.

2013

First export activities started via Oksijen Drug Wholesaler.

2014

Establishment of Avixa Pharma.

2014

Purchasing of Duransol Foot Care Series products, which have been on the market for 21 years in the cosmetics sector, from Koç Pharma.

2015

Getting marketing authorisation rights (licenses) of 8 drugs from Keymen Pharma.

2016

Launching of the pharmaceutical products.

2016

Transferring of Turkey marketing rights of Sanofi’s products named “Ultracain” to Avixa.

2018

Expanding the export capacity to 19 countries by Oksijen Drug Wholesaler.

2019

Establishement of the company named Avigem in order to perform R&D activities.

2019

Getting marketing authorisation rights (licenses) of 26 drugs from Sanofi.

2020

Totally 52 Active drug licenses on behalf of Avixa and marketing activities of 6 Products belonging to Sanofi.

Expect New News From Us ..
TOP